FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer

Drug Information

Target Indication

Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer

Clinical Trial

Last updated: 1/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

MRK

MERCK

Related Pipeline

Bacterial Pneumonia

Hepatitis C

Pneumococcal Infections

Heart Failure

Vomiting